Literature DB >> 6156114

Morquio's disease type A: absence of material cross reacting with antibodies against N-acetylgalactosamine-6-sulfate sulfatase.

J Glössl, K Lembeck, G Gamse, H Kresse.   

Abstract

An antiserum was raised in guinea pigs against purified normal human N-acetylgalactosamine-6-sulfate sulfatase, the enzyme affecting in Morquio's disease type A. The antiserum precipitated most of N-acetylgalactosamine-6-sulfate sulfatase from a concentrate of normal human urine. The antigen-antibody complex was enzymatically active. Urine concentrates from five patients with Morquio's disease type A did not contain material competing with the normal enzyme for binding to soluble or Sepharose-bound antibodies. No precipitin arc was obtained on immunodiffusion of antiserum and urine from the single patient investigated by this method. From the sensitivity of the indirect immunoassay it was concluded that the urine of the five patients contained less than 5% of the normal amount of cross-reacting material.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156114     DOI: 10.1007/BF00279054

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Primary enzyme immunoassay (PEIA): studies of the mutant enzyme in metachromatic leukodystrophy (primary enzyme immunoassay of arylsulfatase-A).

Authors:  E Neuwelt; P F Kohler; J Austin
Journal:  Immunochemistry       Date:  1973-11

2.  The enzymic defect in Morquio's disease: the specificity of N-acetylhexosamine sulfatases.

Authors:  A L Horwitz; A Dorfman
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

3.  Rodent and human acid -glucosidase. Purification, properties and inhibition by antibodies. Investigation in type II glycogenosis.

Authors:  T de Barsy; P Jacquemin; P Devos; H G Hers
Journal:  Eur J Biochem       Date:  1972-11-21

4.  Studies on human beta-D-N-acetylhexosaminidases. 3. Biochemical genetics of Tay-Sachs and Sandhoff's diseases.

Authors:  S K Srivastava; E Beutler
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

5.  A sensitive procedure for the diagnosis of N-acetyl-galactosamine-6-sulfate sulfatase deficiency in classical Morquio's disease.

Authors:  J Glössl; H Kresse
Journal:  Clin Chim Acta       Date:  1978-08-15       Impact factor: 3.786

6.  Purification and properties of N-acetylgalactosamine 6-sulphate sulphatase from human placenta.

Authors:  J Glössl; W Truppe; H Kresse
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

7.  Immunological properties of N-acetyl-beta-D-glucosaminidase of normal human liver and of GM2-gangliosidosis liver.

Authors:  M Carroll; D Robinson
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

8.  Spondyloepiphyseal dysplasia, corneal clouding, normal intelligence and acid beta-galactosidase deficiency.

Authors:  J S O'Brien; E Gugler; A Giedion; U Wiessmann; N Herschkowitz; C Meier; J Leroy
Journal:  Clin Genet       Date:  1976-05       Impact factor: 4.438

9.  Demonstration of cross-reacting material in Tay-Sachs disease.

Authors:  S K Srivastava; N H Ansari; L A Hawkins; J E Wiktorowicz
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

10.  Investigation of the alpha-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme.

Authors:  P J Rietra; J L Molenaar; M N Hamers; J M Tager; P Borst
Journal:  Eur J Biochem       Date:  1974-07-01
View more
  2 in total

1.  Hunter syndrome: presence of material cross-reacting with antibodies against iduronate sulfatase.

Authors:  A Daniele; P Di Natale
Journal:  Hum Genet       Date:  1987-03       Impact factor: 4.132

Review 2.  Review: the immunochemical analysis of enzyme from mucopolysaccharidoses patients.

Authors:  D A Brooks
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.